# Ophthalmic and Topical Dosage Form New Animal Drugs; Gentamicin Sulfate, Mometasone Furoate, Clotrimazole Otic Suspension
> **Food and Drug Administration** · Final rule. · Published 2003-03-31 · Effective 2003-03-31 · 68 FR 15370
## Document
- **Document number:** 03-7534
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 15370
- **CFR reference:** 21 CFR 524
- **Publication date:** 2003-03-31
- **Effective date:** 2003-03-31
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The supplemental NADA provides for the addition of once-daily administration to the dosage regimens for gentamicin/mometasone/ clotrimazole otic suspension used to treat otitis externa in dogs and for revision of the indications to reflect a current format.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/03/31/03-7534/ophthalmic-and-topical-dosage-form-new-animal-drugs-gentamicin-sulfate-mometasone-furoate)
---
*AI Analytics · CC0 1.0*